NJ SNIP: Supporting Behavioral Health Access Through Trust-based Grantmaking
Amid shifting federal health care funding, grants that enable health care safety net entities to respond to the changing landscape can unlock immense value. This form of grantmaking puts daily program-related decisions in the hands of people doing the work, allowing organizations to develop and sustain staff positions, workflows, and programs that reflect their priorities.
Leaning Into Radical Collaboration Will Advance Your Focused Mission
At this year’s GIH annual conference, I found myself surrounded by hundreds of philanthropic leaders deeply committed to improving the health and well-being of their communities. Again and again, I met funders whose work was grounded in a particular place, population, or issue. These funders know their communities intimately. They understand local history, relationships, and the needs of their communities. Their focus is one of their greatest strengths.
GIH Health Policy Update Newsletter
An Exclusive Resource for Funding Partners
The Health Policy Update is a newsletter produced in collaboration with Leavitt Partners and Trust for America’s Health. Drawing on GIH’s policy priorities outlined in our policy agenda and our strategic objective of increasing our policy and advocacy presence, the Health Policy Update provides GIH Funding Partners with a range of federal health policy news.
Power to the People: Advancing Impact Through Participatory Budgeting
Who is best positioned to determine how health funding should be allocated? At the Community Health Commission of Missouri (CHCM), we believe the answer is clear: the people most affected by health disparities.
How Pew Is Learning to Improve Health Policy
Antibiotics revolutionized medical treatment and are a cornerstone of modern health care. However, the global rise of antibiotic-resistant bacteria is making infections costlier and deadlier. After a 2008 report commissioned by The Pew Charitable Trusts highlighted these concerns, the organization invested in multiple projects to set limits on the use of antibiotics and to spur the development of new drugs.










